Mai Tuyet Pho to Drug Costs
This is a "connection" page, showing publications Mai Tuyet Pho has written about Drug Costs.
Connection Strength
0.503
-
Valuing cure: bridging cost-effectiveness and coverage decisions for hepatitis C therapy. Hepatology. 2014 Jul; 60(1):12-4.
Score: 0.468
-
Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017 04; 11(4):e0005459.
Score: 0.035